Letter of Intent Deadline: March 1
Proposal Deadline: May 1
The ACRI/ABI Postgraduate Grant intramural grant mechanism was created to support investigator-initiated, hypothesis-driven (goal-directed) research directed by trainees conducting pediatric research. Eligible candidates include those with M.D., Ph.D., M.D./Ph.D, PharmD, or PharmD/Ph.D. degrees who are in their second year of postgraduate training. All trainees must apply with a mentor who is a full-time UAMS faculty member. Click here to view the RFA.
Letter of Intent Deadline: August 1
Proposal Deadline: October 1
The ACRI/ABI Nursing and Allied Health Research Grant intramural grant mechanism was created to support investigator-initiated, hypothesis-driven (goal-directed) research directed by nurses and allied health professionals conducting pediatric research on an Arkansas Children's, Inc, campus. Eligible candidates include those with a terminal professional degree required for their discipline. If the applicant is pursuing a graduate degree, that applicant must include a detailed mentoring plan and a mentoring statement by an Arkansas Children's staff member. Click here to view the RFA.
Letter of Intent Deadline: December 1
Proposal Deadline: February 1
A generous gift from a private donor endows the Marion B. Lyon New Scientist Development Program. This program was established to support highly promising beginning scientists who are working to become independent investigators but who have yet to receive specific types of NIH funding. Eligible candidates must hold MD, PhD, or have equivalent doctoral degree earned at the time of submission (at the rank of Instructor or Assistant Professor) and must be based full time on an Arkansas Children's, Inc, campus. Click here to view the RFA.
Applications are accepted on a rolling basis.
The Arkansas Children’s Catalyst Program is intended to provide entrepreneurial mentorship and seed funding to Arkansas Children’s scientists and innovators for developing promising ideas. The focus of proposals should be on the development of therapeutics, diagnostics, medical devices, digital health, and biological tools related to improving child health outcomes. Click here to view the RFA.